Mehrdad Oveisi

Morteza Alizadeh, Mehrdad Oveisi, Sonya Falahati et al.

Machine learning (ML) models rely heavily on consistent and accurate performance metrics to evaluate and compare their effectiveness. However, existing libraries often suffer from fragmentation, inconsistent implementations, and insufficient data validation protocols, leading to unreliable results. Existing libraries have often been developed independently and without adherence to a unified standard, particularly concerning the specific tasks they aim to support. As a result, each library tends to adopt its conventions for metric computation, input/output formatting, error handling, and data validation protocols. This lack of standardization leads to both implementation differences (ID) and reporting differences (RD), making it difficult to compare results across frameworks or ensure reliable evaluations. To address these issues, we introduce AllMetrics, an open-source unified Python library designed to standardize metric evaluation across diverse ML tasks, including regression, classification, clustering, segmentation, and image-to-image translation. The library implements class-specific reporting for multi-class tasks through configurable parameters to cover all use cases, while incorporating task-specific parameters to resolve metric computation discrepancies across implementations. Various datasets from domains like healthcare, finance, and real estate were applied to our library and compared with Python, Matlab, and R components to identify which yield similar results. AllMetrics combines a modular Application Programming Interface (API) with robust input validation mechanisms to ensure reproducibility and reliability in model evaluation. This paper presents the design principles, architectural components, and empirical analyses demonstrating the ability to mitigate evaluation errors and to enhance the trustworthiness of ML workflows.

Mohammad R. Salmanpour, Amir Hossein Pouria, Sonia Falahati et al.

Background: CT imaging is vital for lung cancer management, offering detailed visualization for AI-based prognosis. However, supervised learning SL models require large labeled datasets, limiting their real-world application in settings with scarce annotations. Methods: We analyzed CT scans from 977 patients across 12 datasets extracting 1218 radiomics features using Laplacian of Gaussian and wavelet filters via PyRadiomics Dimensionality reduction was applied with 56 feature selection and extraction algorithms and 27 classifiers were benchmarked A semi supervised learning SSL framework with pseudo labeling utilized 478 unlabeled and 499 labeled cases Model sensitivity was tested in three scenarios varying labeled data in SL increasing unlabeled data in SSL and scaling both from 10 percent to 100 percent SHAP analysis was used to interpret predictions Cross validation and external testing in two cohorts were performed. Results: SSL outperformed SL, improving overall survival prediction by up to 17 percent. The top SSL model, Random Forest plus XGBoost classifier, achieved 0.90 accuracy in cross-validation and 0.88 externally. SHAP analysis revealed enhanced feature discriminability in both SSL and SL, especially for Class 1 survival greater than 4 years. SSL showed strong performance with only 10 percent labeled data, with more stable results compared to SL and lower variance across external testing, highlighting SSL's robustness and cost effectiveness. Conclusion: We introduced a cost-effective, stable, and interpretable SSL framework for CT-based survival prediction in lung cancer, improving performance, generalizability, and clinical readiness by integrating SHAP explainability and leveraging unlabeled data.

Mohammad R. Salmanpour, Morteza Alizadeh, Ghazal Mousavi et al.

This study evaluates metrics for tasks such as classification, regression, clustering, correlation analysis, statistical tests, segmentation, and image-to-image (I2I) translation. Metrics were compared across Python libraries, R packages, and Matlab functions to assess their consistency and highlight discrepancies. The findings underscore the need for a unified roadmap to standardize metrics, ensuring reliable and reproducible ML evaluations across platforms. This study examined a wide range of evaluation metrics across various tasks and found only some to be consistent across platforms, such as (i) Accuracy, Balanced Accuracy, Cohens Kappa, F-beta Score, MCC, Geometric Mean, AUC, and Log Loss in binary classification; (ii) Accuracy, Cohens Kappa, and F-beta Score in multi-class classification; (iii) MAE, MSE, RMSE, MAPE, Explained Variance, Median AE, MSLE, and Huber in regression; (iv) Davies-Bouldin Index and Calinski-Harabasz Index in clustering; (v) Pearson, Spearman, Kendall's Tau, Mutual Information, Distance Correlation, Percbend, Shepherd, and Partial Correlation in correlation analysis; (vi) Paired t-test, Chi-Square Test, ANOVA, Kruskal-Wallis Test, Shapiro-Wilk Test, Welchs t-test, and Bartlett's test in statistical tests; (vii) Accuracy, Precision, and Recall in 2D segmentation; (viii) Accuracy in 3D segmentation; (ix) MAE, MSE, RMSE, and R-Squared in 2D-I2I translation; and (x) MAE, MSE, and RMSE in 3D-I2I translation. Given observation of discrepancies in a number of metrics (e.g. precision, recall and F1 score in binary classification, WCSS in clustering, multiple statistical tests, and IoU in segmentation, amongst multiple metrics), this study concludes that ML evaluation metrics require standardization and recommends that future research use consistent metrics for different tasks to effectively compare ML techniques and solutions.

Sajad Amiri, Shahram Taeb, Sara Gharibi et al.

Gadolinium-based contrast agents (GBCAs) are central to glioma imaging but raise safety, cost, and accessibility concerns. Predicting contrast enhancement from non-contrast MRI using machine learning (ML) offers a safer alternative, as enhancement reflects tumor aggressiveness and informs treatment planning. Yet scanner and cohort variability hinder robust model selection. We propose a stability-aware framework to identify reproducible ML pipelines for multicenter prediction of glioma MRI contrast enhancement. We analyzed 1,446 glioma cases from four TCIA datasets (UCSF-PDGM, UPENN-GB, BRATS-Africa, BRATS-TCGA-LGG). Non-contrast T1WI served as input, with enhancement derived from paired post-contrast T1WI. Using PyRadiomics under IBSI standards, 108 features were extracted and combined with 48 dimensionality reduction methods and 25 classifiers, yielding 1,200 pipelines. Rotational validation was trained on three datasets and tested on the fourth. Cross-validation prediction accuracies ranged from 0.91 to 0.96, with external testing achieving 0.87 (UCSF-PDGM), 0.98 (UPENN-GB), and 0.95 (BRATS-Africa), with an average of 0.93. F1, precision, and recall were stable (0.87 to 0.96), while ROC-AUC varied more widely (0.50 to 0.82), reflecting cohort heterogeneity. The MI linked with ETr pipeline consistently ranked highest, balancing accuracy and stability. This framework demonstrates that stability-aware model selection enables reliable prediction of contrast enhancement from non-contrast glioma MRI, reducing reliance on GBCAs and improving generalizability across centers. It provides a scalable template for reproducible ML in neuro-oncology and beyond.

Isaac Shiri, Hassan Maleki, Ghasem Hajianfar et al.

Aim: In the present work, we aimed to evaluate a comprehensive radiomics framework that enabled prediction of EGFR and KRAS mutation status in NSCLC cancer patients based on PET and CT multi-modalities radiomic features and machine learning (ML) algorithms. Methods: Our study involved 211 NSCLC cancer patient with PET and CTD images. More than twenty thousand radiomic features from different image-feature sets were extracted Feature value was normalized to obtain Z-scores, followed by student t-test students for comparison, high correlated features were eliminated and the False discovery rate (FDR) correction were performed Six feature selection methods and twelve classifiers were used to predict gene status in patient and model evaluation was reported on independent validation sets (68 patients). Results: The best predictive power of conventional PET parameters was achieved by SUVpeak (AUC: 0.69, P-value = 0.0002) and MTV (AUC: 0.55, P-value = 0.0011) for EGFR and KRAS, respectively. Univariate analysis of radiomics features improved prediction power up to AUC: 75 (q-value: 0.003, Short Run Emphasis feature of GLRLM from LOG preprocessed image of PET with sigma value 1.5) and AUC: 0.71 (q-value 0.00005, The Large Dependence Low Gray Level Emphasis from GLDM in LOG preprocessed image of CTD sigma value 5) for EGFR and KRAS, respectively. Furthermore, the machine learning algorithm improved the perdition power up to AUC: 0.82 for EGFR (LOG preprocessed of PET image set with sigma 3 with VT feature selector and SGD classifier) and AUC: 0.83 for KRAS (CT image set with sigma 3.5 with SM feature selector and SGD classifier). Conclusion: We demonstrated that radiomic features extracted from different image-feature sets could be used for EGFR and KRAS mutation status prediction in NSCLC patients, and showed that they have more predictive power than conventional imaging parameters.